Inactivation of specific β cell transcription factors in type 2 diabetes
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes (T2DM) commonly arises from islet β cell failure and insulin resistance. Here, we examined the sensitivity of key islet-enriched transcription factors to oxidative stress, a condition associated with β cell dysfunction in both type 1 diabetes (T1DM) and T2DM. Hydrogen peroxide treatment of β cell lines induced cytoplasmic translocation of MAFA and NKX6.1. In parallel, the ability of nuclear PDX1 to bind endogenous target gene promoters was also dramatically reduced, whereas the activity of other key β cell transcriptional regulators was unaffected. MAFA levels were reduced, followed by a reduction in NKX6.1 upon development of hyperglycemia in db/db mice, a T2DM model. Transgenic expression of the glutathione peroxidase-1 antioxidant enzyme (GPX1) in db/db islet β cells restored nuclear MAFA, nuclear NKX6.1, and β cell function in vivo. Notably, the selective decrease in MAFA, NKX6.1, and PDX1 expression was found in human T2DM islets. MAFB, a MAFA-related transcription factor expressed in human β cells, was also severely compromised. We propose that MAFA, MAFB, NKX6.1, and PDX1 activity provides a gauge of islet β cell function, with loss of MAFA (and/or MAFB) representing an early indicator of β cell inactivity and the subsequent deficit of more impactful NKX6.1 (and/or PDX1) resulting in overt dysfunction associated with T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oxidative stress can inactivate key islet transcription factors, producing “stunned” β-cells that temporarily stop responding to glucose and storing normal amounts of insulin ( 36 , 37 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303 · cited 1×
“Time PCR Experiments (MIQE) guidelines were followed (78).”
Identification and expression cloning of a leptin receptor, OB-R.
Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90151-5 · Cited by 3,496 · cited 1×
“The db/db mouse is a model of obesity and T2DM due to a deficiency in leptin receptor activity (45, 46).”
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232 · cited 1×
“Oxidative stress induces modifications within proteins, and these modifications impact activity (55, 56), stability (57, 58), and/or subcellular distribution (40, 41).”
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214 · cited 1×
“The db/db mouse is a model of obesity and T2DM due to a deficiency in leptin receptor activity (45, 46).”
Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells
D'Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G., Agulnick, A. D., Smart, N. G., Moorman, M. A., Kroon, E., Carpenter, M. K., & Baetge, E. E. (2006) · Nature Biotechnology · doi:10.1038/nbt1259 · Cited by 1,915
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415 · cited 4×
“parity and aging in mice lacking FOXO1 in β cells (47).”
InfluentialTiedge, M., Lortz, S., Drinkgern, J., & Lenzen, S. (1997) · Diabetes · doi:10.2337/diab.46.11.1733 · Cited by 1,208 · cited 1×
“Nota-bly, islet β cells have unusually low antioxidant enzyme levels (e.g., glutathione peroxidase-1 [GPX1] and catalase), thus exposing their proteins, lipids, and/or DNA to oxidative modifications (10, 11).”
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078 · cited 2×
“These data suggest that β cell inactivity results from the stepwise loss of MAFA and then PDX1 under glucotoxic conditions (22, 23, 28).”
Self-citation
Cited by
Items 101–200 of 516
Pancreatic β-cell heterogeneity in health and diabetes: classes, sources, and subtypes
Miranda, M. A., Macias-Velasco, J. F., & Lawson, H. A. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00649.2020 · Cited by 78
Revealing transcription factors during human pancreatic β cell development
Conrad, E., Stein, R., & Hunter, C. S. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.03.013 · Cited by 69
“Recently, reductions of MAFA levels were found in db/db mice and in human T2DM islets, potentially a signature of dysfunctional β cells [25].”
BackgroundInfluentialSelf-citationAmo-Shiinoki, K., Tanabe, K., Hoshii, Y., Matsui, H., Harano, R., Fukuda, T., Takeuchi, T., Bouchi, R., Takagi, T., Hatanaka, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143791 · Cited by 74
Casellas, A., Mallol, C., Salavert, A., Jiménez, V., García, M., Agudo, J., Obach, M., Haurigot, V., Vilà, L., Molas, M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642041 · Cited by 74
“Other authors have also used the term dedifferentiation to describe the loss of -cell identity due to the inactivation of transcription factors that define -cell fate (7, 8).”
Background12-Lipoxygenase Promotes Obesity-Induced Oxidative Stress in Pancreatic Islets
Tersey, S. A., Maier, B., Nishiki, Y., Maganti, A. V., Nadler, J. L., & Mirmira, R. G. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00157-14 · Cited by 69
“In this context, the overexpression of Gpx1 in islets of db/db diabetic mice protect against long-term hyperglycemia, partly through the restoration of cell transcription factor expression (44, 45).”
BackgroundNormal and defective pathways in biogenesis and maintenance of the insulin storage pool
Liu, M. R., Huang, Y., Xu, X., Li, X., Alam, M., Arunagiri, A., Haataja, L., Ding, L., Wang, S., Itkin‐Ansari, P., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142240 · Cited by 67
Piran, R., Lee, S.-H., Li, C.-R., Charbono, A., Bradley, L. M., & Levine, F. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.311 · Cited by 66
Circular RNA circGlis3 protects against islet β-cell dysfunction and apoptosis in obesity
Liu, Y., Yang, Y., Xu, C., Liu, J., Chen, J., Li, G., Huang, B., Pan, Y., Zhang, Y., Wei, Q., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35998-z · Cited by 72
Fernández‐Millán, E., Martín, M. Á., Goya, L., Lizárraga-Mollinedo, E., Escrivá, F., Ramos, S., & Álvarez, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.002 · Cited by 68
Spaeth, J. M., Gupte, M., Perelis, M., Yang, Y.-P., Cyphert, H. A., Guo, S., Liu, J., Guo, M. A., Bass, J. T., Magnuson, M. A., et al. (2017) · Diabetes · doi:10.2337/db16-1516 · Cited by 75
“Pdx1 +/ 2 served as the control in our analysis, because the heterozygous mutant is not only associated with type 2 diabetes (T2D) in humans (3,4) but also causes reduced islet b -cell function and mass in mice (29).”
Self-citationGenomics of Islet (Dys)function and Type 2 Diabetes
Lawlor, N. T., Khetan, S., Ucar, D., & Stitzel, M. L. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.01.010 · Cited by 71
Burke, S. J., Batdorf, H. M., Burk, D. H., Martin, T. M., Mendoza, T. M., Stadler, K., Alami, W., Karlstad, M. D., Robson, M. J., Blakely, R., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.003 · Cited by 68
McKenna, B. D., Guo, M. A., Reynolds, A. B., Hara, M., & Stein, R. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.054 · Cited by 64
“…March 31, 2015 ª2015 The Authors PDX1 Recruitment of BRG1-SWI/ SNF Is Compromised in Human T2DM Islet b Cells Reduced levels of a small subset of isletenriched transcription factors contribute to T2DM b cell dysfunction, with PDX1 among the specifically affected factors (Guo et al., 2013).”
InfluentialSelf-citationKimmel, R. A., Dobler, S., Schmitner, N., Walsen, T., Freudenblum, J., & Meyer, D. (2015) · Scientific Reports · doi:10.1038/srep14241 · Cited by 72
Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion
Fine, N. H. F., Doig, C. L., Elhassan, Y. S., Vierra, N. C., Marchetti, P., Bugliani, M., Nano, R., Piemonti, L., Rutter, G. A., Jacobson, D. A., et al. (2018) · Diabetes · doi:10.2337/db16-1356 · Cited by 61
Human duct cells contribute to β cell compensation in insulin resistance
Dirice, E., Jesus, D. F. D., Kahraman, S., Basile, G., Ng, R. W. S., Ouaamari, A. E., Teo, A. K. K., Bhatt, S., Hu, J., & Kulkarni, R. (2019) · JCI Insight · doi:10.1172/jci.insight.99576 · Cited by 67
Type 2 Diabetes–Associated Genetic Variants Regulate Chromatin Accessibility in Human Islets
Khetan, S., Kursawe, R., Youn, A., Lawlor, N. T., Jillette, A., Márquez, E. J., Ucar, D., & Stitzel, M. L. (2018) · Diabetes · doi:10.2337/db18-0393 · Cited by 71
“responses, such as ATF3/JUNB, AP-1, and BACH1, were enriched in closing OCRs, which may represent epigenomic signatures of previously described molecular perturbations in dysfunctional and T2D islets, including PDX1 export from the nucleus (44), perturbation of oxidative stress responses (45,46), and inactivation of b…”
BackgroundBeta-Cell Dedifferentiation in Type 2 Diabetes: Concise Review
Efrat, S. (2019) · Stem Cells · doi:10.1002/stem.3059 · Cited by 65
A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes
Khin, P. P., Lee, J., & Jun, H. (2021) · Nutrients · doi:10.3390/nu13051593 · Cited by 70
“In immortalized β-cells (INS-1) exposed to high glucose and/or palmitate mimicking glucotoxicity and lipotoxicity, respectively, ROS production was significantly increased, but insulin secretion was decreased via downregulation of MafA expression [18,56].”
BackgroundConrad, E., Dai, C., Spaeth, J., Guo, M., Cyphert, H. A., Scoville, D., Carroll, J., Yu, W.-M., Goodrich, L. V., Harlan, D. M., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00285.2015 · Cited by 61
Self-citationMechanisms of β‐cell functional adaptation to changes in workload
Wortham, M., & Sander, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12729 · Cited by 71
Self-citationKarunakaran, U., Elumalai, S., Moon, J. S., Jeon, J., Kim, N. D., Park, K., Won, K. C., Leem, J., & Lee, I. K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0052 · Cited by 67
Kim-Muller, J. Y., Kim, Y. J. R., Fan, J., Zhao, S., Banks, A. S., Prentki, M., & Accili, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705608 · Cited by 64
Epigenetic changes in diabetes
Al-Haddad, R., Karnib, N., Assaad, R. A., Bilen, Y., Emmanuel, N., Ghanem, A., Younes, J., Zibara, V., Stephan, J. S., & Sleiman, S. F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.046 · Cited by 58
Kuo, T., Kraakman, M. J., Damle, M., Gill, R., Lazar, M. A., & Accili, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904311116 · Cited by 63
Periodontitis as a promoting factor of T2D: current evidence and mechanisms
Su, Y., Ye, L., Hu, C., Zhang, Y., Liu, J., & Shao, L. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00227-2 · Cited by 64
Pancreatic islet cell development and regeneration
Romer, A. I., & Sussel, L. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000174 · Cited by 62
Transcriptional mechanisms of pancreatic β-cell maturation and functional adaptation
Wortham, M., & Sander, M. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.04.011 · Cited by 62
Self-citationMinireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes
Tersey, S. A., Bolanis, E., Holman, T. R., Maloney, D. J., Nadler, J. L., & Mirmira, R. G. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1041 · Cited by 61
β- cell dynamics in type 2 diabetes and in dietary and exercise interventions
Lv, C.-A., Sun, Y., Zhang, Z. Y., Aboelela, Z., Qiu, X., & Meng, Z. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac046 · Cited by 62
Neuropeptide Y expression marks partially differentiated β cells in mice and humans
Rodnoi, P., Rajkumar, M. S., Moin, A. S. M., Georgia, S. K., Butler, A. E., & Dhawan, S. (2017) · JCI Insight · doi:10.1172/jci.insight.94005 · Cited by 59
“Impairment of β cell maturity contributes to β cell dysfunction in diabetes (17, 18, 35).”
BackgroundInfluentialRedox Homeostasis in Pancreatic β-Cells: From Development to Failure
Benáková, Š., Holendová, B., & Plecitá‐Hlavatá, L. (2021) · Antioxidants · doi:10.3390/antiox10040526 · Cited by 64
Spaeth, J. M., Hunter, C. S., Bonatakis, L., Guo, M. A., French, C. A., Slack, I. F., Hara, M., Fisher, S. E., Ferrer, J. P., Morrisey, E. E., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3635-3 · Cited by 54
Self-citationThomas, A. P., Hoang, J. D., Vongbunyong, K. E., Nguyen, A., Rakshit, K., & Matveyenko, A. V. (2016) · Endocrinology · doi:10.1210/en.2016-1309 · Cited by 60
“CDO islets display disrupted architecture characterized by increased frequency of -cell apoptosis as well as increased -cell turnover, observations consistent with models of obesity-induced -cell failure (34) and humans with T2DM (35).”
ResultBitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia
Mattè, A., Federti, E., Winter, M., Koerner, A., Harmeier, A., Mazer, N. A., Tomka, T., Paolo, M. L. D., Falco, L. D., Andolfo, I., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130111 · Cited by 56
Wu, T., Zhang, S., Xu, J., Zhang, Y., Sun, T., Shao, Y., Wang, J., Tang, W., Chen, F., & Han, X. (2020) · Diabetes · doi:10.2337/db19-1060 · Cited by 56
Increased glycolysis affects β-cell function and identity in aging and diabetes
Murao, N., Yokoi, N., Takahashi, H., Hayami, T., Minami, Y., & Seino, S. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101414 · Cited by 61
Recessive Mutations in PCBD1 Cause a New Type of Early-Onset Diabetes
Šimaitė, D., Kofent, J., Gong, M., Rüschendorf, F., Jia, S., Arn, P. H., Bentler, K., Ellaway, C., Kühnen, P., Hoffmann, G. F., et al. (2014) · Diabetes · doi:10.2337/db13-1784 · Cited by 60
Alfar, E. A., Kirova, D., Konantz, J., Birke, S., Mansfeld, J., & Ninov, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-03873-9 · Cited by 56
Abu‐Gazala, S., Horwitz, E. P., Schyr, R. B., Bardugo, A., Israeli, H., Hija, A., Schug, J., Shin, S., Dor, Y., Kaestner, K. H., et al. (2018) · Diabetes · doi:10.2337/db17-1028 · Cited by 56
Regulation of Pdx1 by oxidative stress and Nrf2 in pancreatic beta-cells
Baumel-Alterzon, S., & Scott, D. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011187 · Cited by 61
Shafagh, R. Z., Youhanna, S. C., Keulen, J., Shen, J. X., Taebnia, N., Preiss, L. C., Klein, K., Büttner, F., Bergqvist, M., van der Wijngaart, W., et al. (2022) · Advanced Science · doi:10.1002/advs.202203368 · Cited by 60
Pan, F. C., Briššová, M., Powers, A. C., Pfaff, S. L., & Wright, C. V. E. (2015) · Development · doi:10.1242/dev.126011 · Cited by 61
“Because MafA nuclear localization is usually wellestablished by P4, and is indicative of mature β-cell status (Guo et al., 2013), we tested for its presence and subcellular localization in mutant β-cells.”
BackgroundSelf-citationKimura, T., Obata, A., Shimoda, M., Okauchi, S., Kanda‐Kimura, Y., Nogami, Y., Moriuchi, S., Hirukawa, H., Kohara, K., Nakanishi, S., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13400 · Cited by 55
Burke, S. J., Karlstad, M. D., Regal, K. M., Sparer, T. E., Lu, D., Elks, C. M., Grant, R. W., Stephens, J. M., Burk, D. H., & Collier, J. J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.03.007 · Cited by 54
MafB Is Critical for Glucagon Production and Secretion in Mouse Pancreatic α Cells In Vivo
Katoh, M., Jung, Y., Ugboma, C. M., Shimbo, M., Kuno, A., Basha, W. A. A., Kudo, T., Oishi, H., & Takahashi, S. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00504-17 · Cited by 54
Walker, E. M., Cha, J., Tong, X., Guo, M., Liu, J.-H., Yu, S., Iacovazzo, D., Mauvais-Jarvis, F., Flanagan, S. E., Korbonits, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109813 · Cited by 48
“, 2005) and human (Guo et al., 2013) β cell activity.”
Self-citationPost-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update
Rodríguez‐Rodríguez, A. E., Porrini, E., Hornum, M., Donate‐Correa, J., Febles, R. M., Ramchand, S. K., Lima, M. X. M., & Torres, A. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000514288 · Cited by 52
DNA Methylation Patterning and the Regulation of Beta Cell Homeostasis
Parveen, N., & Dhawan, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651258 · Cited by 50
dos Santos, C., Cambraia, A., Shrestha, S., Cutler, M., Cottam, M. A., Perkins, G. A., Lev‐Ram, V., Roy, B., Acree, C., Kim, K.-Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53127-2 · Cited by 55
Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?
Rodríguez‐Rodríguez, A. E., Porrini, E., & Torres, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910311 · Cited by 51
Role of the Transcription Factor MAFA in the Maintenance of Pancreatic β-Cells
Nishimura, W., Iwasa, H., & Tumurkhuu, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094478 · Cited by 53
Vitamin A: a missing link in diabetes?
Trasino, S. E., & Gudas, L. J. (2015) · Diabetes Management · doi:10.2217/dmt.15.30 · Cited by 51
Nrf2 Regulates β-Cell Mass by Suppressing β-Cell Death and Promoting β-Cell Proliferation
Baumel-Alterzon, S., Katz, L. S., Brill, G., Jean-Pierre, C., Li, Y., Tse, I., Biswal, S. S., García-Ocaña, A., & Scott, D. K. (2022) · Diabetes · doi:10.2337/db21-0581 · Cited by 50
Kang, L., Dai, C., Lustig, M. E., Bonner, J. S., Mayes, W. H., Mokshagundam, S., James, F. D., Thompson, C. S., Lin, C.-T., Perry, C. G. R., et al. (2014) · Diabetes · doi:10.2337/db13-1845 · Cited by 46
Self-citationJohnson, J. S., Kono, T., Tong, X., Yamamoto, W. R., Zarain‐Herzberg, Á., Merrins, M. J., Satin, L. S., Gilon, P., & Evans‐Molina, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575191 · Cited by 51
Examining How the MAFB Transcription Factor Affects Islet β-Cell Function Postnatally
Cyphert, H. A., Walker, E. M., Hang, Y., Dhawan, S., Haliyur, R., Bonatakis, L., Avrahami, D., Briššová, M., Kaestner, K. H., Bhushan, A., et al. (2018) · Diabetes · doi:10.2337/db18-0903 · Cited by 48
Self-citationCombinatorial transcription factor profiles predict mature and functional human islet α and β cells
Shrestha, S., Saunders, D. C., Walker, J. T., Camuñas-Soler, J., Dai, X.-Q., Haliyur, R., Aramandla, R., Poffenberger, G., Prasad, N., Bottino, R., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151621 · Cited by 52
“(14) consequences compared to other β cells, we utilized human Patch-seq data from Camunas et 274 al.”
Self-citationCould microRNAs contribute to the maintenance of β cell identity?
Kaspi, H., Pasvolsky, R., & Hornstein, E. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.01.003 · Cited by 45
Beta-cell mitochondrial carriers and the diabetogenic stress response
Brun, T., & Maechler, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.012 · Cited by 50
“Interestingly, human transcript levels of the β-cell specific transcription factor MAFA [98] and the C5 and C4 mitochondrial carriers GC1 and UCP2 are down-regulated following oxidative stress [94], similarly to INS-1E βcells [93], conferring to these targets a stress-specific signature (Fig.”
BackgroundImpact of Pdx1‐associated chromatin modifiers on islet β‐cells
Spaeth, J. M., Walker, E. M., & Stein, R. W. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12730 · Cited by 45
“Importantly, reduced levels of human PDX1 are associated with and thought to contribute to the T2D β-cell dysfunction.(12) Complete removal of Pdx1 specifically from mature β-cells resulted in severe hyperglycaemia coupled with a transcriptional shift of the insulin cell population to an α-like cell phenotype.”
BackgroundSelf-citationIncreased vimentin in human α- and β-cells in type 2 diabetes
Roefs, M. M., Carlotti, F., Jones, K., WILLS, H. J., Hamilton, A., Verschoor, M., Durkin, J. M. W., García-Pérez, L., Brereton, M. F., McCulloch, L. J., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0588 · Cited by 51
“However, both the downregulation of key transcription factors (Hay & Docherty 2006, Butler et al. 2012, Szabat et al. 2012, Guo et al. 2013, Schaffer et al. 2013, Gao et al. 2014) and the expression of vimentin in islet cells (Gershengorn et al. 2004, Russ et al. 2009) have been associated with β…”
A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes
Du, Z., & Uversky, V. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102010 · Cited by 48
“The loss of these central factors leads to significant reductions in the expression of their gene targets, including insulin, solute carrier family 2, facilitated glucose transporter member 2 (SLC2A2), and glucagon-like peptide 1 receptor (GLP1R), all of which are critical to β-cell glucose-sensing and insulin secreti…”
BackgroundDoes Disruption of Circadian Rhythms Contribute to Beta-Cell Failure in Type 2 Diabetes?
Rakshit, K., Thomas, A. P., & Matveyenko, A. V. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0474-4 · Cited by 48
Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure
Fan, J., Du, W. J., Kim-Muller, J. Y., Son, J., Kuo, T., Larrea, D., Garcia, C., Kitamoto, T., Kraakman, M. J., Owusu-Ansah, E., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.12.008 · Cited by 44
“Our work focuses on β-cell dedifferentiation as a mechanism of β-cell dysfunction [7-13].”
BackgroundRaptor determines β-cell identity and plasticity independent of hyperglycemia in mice
Yin, Q., Ni, Q., Wang, Y., Zhang, H., Li, W., Nie, A., Wang, S., Gu, Y., Wang, Q., & Ning, G. (2020) · Nature Communications · doi:10.1038/s41467-020-15935-0 · Cited by 42
Mallone, R., Halliez, C., Rui, J., & Herold, K. C. (2022) · Diabetes · doi:10.2337/dbi21-0036 · Cited by 44
Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function
Talchai, S. C., & Accili, D. (2015) · Diabetes · doi:10.2337/db14-1696 · Cited by 42
Ganic, E., Singh, T., Luan, C., Fadista, J., Johansson, J. K., Cyphert, H. A., Bennet, H., Storm, P., Prost, G., Ahlenius, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.002 · Cited by 41
“…factor activates genes critical for glucose sensing, insulin production, and secretion (Artner et al., 2010; Hang et al., 2014), and it has been established that MAFA expression is lost in human type 2 diabetes islets most likely contributing to diabetic β cell dysfunction (Guo et al., 2013).”
BackgroundSelf-citationTargeting β-cell dedifferentiation and transdifferentiation: opportunities and challenges
Wang, W., & Zhang, C. (2021) · Endocrine Connections · doi:10.1530/ec-21-0260 · Cited by 43
Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes
Sun, T., & Han, X. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.12.002 · Cited by 47
Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans
Esguerra, J. L. S., & Eliasson, L. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00209 · Cited by 41
A Small-Molecule Inducer of PDX1 Expression Identified by High-Throughput Screening
Yuan, Y., Hartland, K., Bošković, Ž., Wang, Y., Walpita, D., Lysy, P. A., Zhong, C., Young, D. W., Kim, Y.-K., Tolliday, N. J., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.10.013 · Cited by 39
“Immunofluorescence revealed PDX1 to be cytoplasmic (Figure S3B), perhaps reflecting an immature or stressed state (Guo et al., 2013; Kawamori et al., 2003; Macfarlane et al., 1999).”
Wang, L., Fan, H., Zhou, L., Wu, Y., Lu, H., & Luo, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.010 · Cited by 43
MafA Regulation in β-Cells: From Transcriptional to Post-Translational Mechanisms
Liang, J., Chirikjian, M. K., Pajvani, U. B., & Bartolomé, A. (2022) · Biomolecules · doi:10.3390/biom12040535 · Cited by 46
Brun, T., Li, N., Jourdain, A. A., Gaudet, P., Duhamel, D., Meyer, J., Bosco, D., & Maechler, P. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv247 · Cited by 44
Zhu, Y., Sun, Y., Zhou, Y., Zhang, Y., Zhang, T., Li, Y., You, W., Chang, X., Li, Y., & Han, X. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz004 · Cited by 38
“Considerable evidence indicates that the transcription factor, XBP1s, drives the expression of ER chaperones and components of the ER-associated degradation (ERAD) to restore ER homeostasis (Gupta et al., 2010; Wu et al., 2015; Sun et al., 2016).”
BackgroundSTAT3 dictates β-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia
Weng, Q., Zhao, M., Zheng, J., Yang, L., Xu, Z., Zhang, Z., Wang, J., Wang, J., Yang, B., Lu, Q. R., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0344-3 · Cited by 41
Cataldo, L. R., Vishnu, N., Singh, T., Bertonnier‐Brouty, L., Bsharat, S., Luan, C., Renström, E., Prasad, R. B., Fex, M., Mulder, H., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154734 · Cited by 40
Pancreatic β-Cell Development and Regeneration
Kerper, N. R., Ashe, S., & Hebrok, M. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040741 · Cited by 47
Wu, R. T., Cao, L., Mattson, E., Witwer, K. W., Cao, J., Zeng, H., He, X., Combs, G. F., & Cheng, W. (2017) · Aging Cell · doi:10.1111/acel.12529 · Cited by 37
“Moreover,Gpx1 is necessary to restore nuclear MafA localization for optimal insulin expression in pancreatic bcells of db/db obesemice (Guo et al., 2013).”
BackgroundPhosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice
Zhang, K., Guo, X., Yan, H., Wu, Y., Pan, Q., Shen, Z., Li, X., Chen, Y., Li, L., Qi, Y., et al. (2019) · Endocrinology · doi:10.1210/en.2018-00853 · Cited by 39
Self-citationPRMT1 Is Required for the Maintenance of Mature β-Cell Identity
Kim, H., Yoon, B.-H., Oh, C.-M., Lee, J., Lee, K., Song, H., Kim, E., Yi, K., Kim, M., Kim, H., et al. (2020) · Diabetes · doi:10.2337/db19-0685 · Cited by 38
Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?
Tanday, N., Tarasov, A. I., Moffett, R. C., Flatt, P. R., & Irwin, N. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15300 · Cited by 40
“41,139 Similarly, as noted above, β -cell dedifferentiation is described in db/db mice, 45 with the overexpression of the antioxidant enzyme glutathione peroxidase preserving β -cell MafA expression and alleviating diabetic symptoms.”
BackgroundTakahashi, K., Nakamura, A., Miyoshi, H., Nomoto, H., Kitao, N., Omori, K., Yamamoto, K., Cho, K. Y., Terauchi, Y., & Atsumi, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-25126-z · Cited by 36
YY1 deficiency in β-cells leads to mitochondrial dysfunction and diabetes in mice
Song, D., Yang, Q., Jiang, X., Shan, A., Nan, J., Lei, Y., Ji, H., Wei, D., Yang, T., Wang, T., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154353 · Cited by 38
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
Mandaliya, D. K., & Seshadri, S. (2019) · Pancreatology · doi:10.1016/j.pan.2019.04.013 · Cited by 43
Sheng, C., Li, F., Lin, Z., Zhang, M., Yang, P., Bu, L., Sheng, H., Li, H., & Qu, S. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6035046 · Cited by 38
“Similar results have been previously reported [6].”
BackgroundRabbani, N., & Thornalley, P. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1268308 · Cited by 44
Tanday, N., Irwin, N., Flatt, P. R., & Moffett, R. C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114009 · Cited by 36
Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass
George, N. M., Boerner, B. P., Mir, S. U. R., Guinn, Z. P., & Sarvetnick, N. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1375 · Cited by 37
Reversal of angiotensin ll-induced β-cell dedifferentiation via inhibition of NF-κb signaling
Chen, H., Zhou, W., Ruan, Y., Yang, L., Xu, N., Chen, R., Yang, R., Sun, J. M., & Zhang, Z. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0044-3 · Cited by 37
Chromatin Regulators in Pancreas Development and Diabetes
Campbell, S. A., & Hoffman, B. G. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.12.005 · Cited by 36
Ganić, E., Johansson, J. K., Bennet, H., Fex, M., & Artner, I. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.002 · Cited by 37
A 2A adenosine receptors control pancreatic dysfunction in high‐fat‐diet‐induced obesity
Csóka, B., Törő, G., Vindeirinho, J., Varga, Z. V., Koscsó, B., Németh, Z. H., Kókai, E., Antonioli, L., Suleiman, M., Marchetti, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700398r · Cited by 38
Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function
Zhang, M., Yang, C., Zhu, M., Li, Q., Luo, Y., Cheng, H., Geng, R., Xu, X., Cheng, Q., & Liu, Y. (2021) · Diabetologia · doi:10.1007/s00125-021-05389-4 · Cited by 37
“Results of the subcellular localisation of other important transcription factors, such as MafA and BETA2, in beta cells under stress are inconsistent in previous studies [10, 37].”
BackgroundResultThe β-cell glucose toxicity hypothesis: Attractive but difficult to prove
Weir, G. C., Butler, P. C., & Bonner‐Weir, S. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154870 · Cited by 39
Azarova, I. E., Bushueva, O. Y., Konoplya, A. I., & Polonikov, A. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12623 · Cited by 41
“Free radicals have been shown to reduce insulin gene expression through the post-translational repression of musculoaponeurotic fibrosarcoma protein A (Maf A) and pancreatic duodenal homeobox-1 (PDX-1), two key transcriptional factors that bind to the insulin gene promoter.(49,50) In addition, ROS are also known to ac…”
BackgroundGlucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Nakamura, A., Omori, K., & Terauchi, Y. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14459 · Cited by 39
“1) and v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (Mafa).(69) In addition to metabolic stress, marked increases in intracellular calcium may induce mitochondrial damage.”
BackgroundLipid Droplets Protect Human β-Cells From Lipotoxicity-Induced Stress and Cell Identity Changes
Tong, X., & Stein, R. W. (2021) · Diabetes · doi:10.2337/db21-0261 · Cited by 39
“in all human T2D studies (50), which may reflect both the heterogeneity of the disease and/or methodological differences (51).”
BackgroundSelf-citation
Metadata
- Authors
- Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R.
- Affiliations
- Vanderbilt University (US)
- University of California San Diego (US)
- University of Washington (US)
- Corresponding author
- Stein, Roland
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-01
- Volume
- 123
- Issue
- 8
- Pages
- 3305-3316
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3726150
- OpenAlex
- W2117574263
- Cited by
- 520
- References
- 80
- Citations by year
- 2026: 33 · 2025: 30 · 2024: 39 · 2023: 38 · 2022: 45 · 2021: 55 · 2020: 35 · 2019: 43 · 2018: 29 · 2017: 38 · 2016: 45 · 2015: 52 · 2014: 32 · 2013: 6
- FWCI
- 44.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000666)
- Vanderbilt University (DK59637, DK20593, DK58404, CA68485, EY08126, HD15052)
- Vanderbilt University Medical Center (HD15052, DK20593, EY08126, DK58404, CA68485, DK59637)
- National Institutes of Health (5p60dk020593-31, DK-59637, EY08126, CA68485, DK 20593, HD-15052, DK-58404, DK66636)
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center (DK-20593)
- National Eye Institute (P30EY008126)
- National Cancer Institute (P30CA068485)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK68854, DK-090570, DK089538, P60-DK020593, U01DK089572, DK-89572, DK66636, DK59637, DK-72473, R21DK066636, R21DK068854, DK-58404, DK 20593, U01DK089538, U24DK059637, R56DK038325, DK068471, DK050203, DK038325, R01DK069603, R01DK038325, R33DK066636, R01DK050203, U01DK072473, R56DK050203, R01DK068471, P30DK058404, P30DK020593, R01DK090570)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 2 diabetes, pancreatic beta cells, beta-cell dysfunction, transcription factors, MafA, MAFB, NKX6.1, PDX1, oxidative stress, hydrogen peroxide, glutathione peroxidase 1, db/db mice, insulin resistance, islet function, nuclear translocation
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, HeLa Cells, Humans, Organ Specificity, Transcription Factors, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.